Yubao Zheng

机构：Sun Yat-sen University, Third Affiliated Hospital of Sun Yat-sen University · ORCID：0000-0002-2630-2563

发表论文 81 篇 · 总被引 1408 次 · h-index 18

代表论文

• Metabolic biomarkers significantly enhance the prediction of HBV-related ACLF occurrence and outcomes (2023 · Journal of Hepatology · 被引 53)
• A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease (2024 · Hepatology International · 被引 33)
• Association of AST/ALT ratio with 90-day outcomes in patients with acute exacerbation of chronic liver disease: a prospective multicenter cohort study in China (2024 · Frontiers in Medicine · 被引 22)
• Hepatitis B Virus Reactivation Increased the Risk of Developing Hepatic Failure and Mortality in Cirrhosis With Acute Exacerbation (2022 · Frontiers in Microbiology · 被引 21)
• Addition of transarterial chemoembolization improves outcome of tyrosine kinase and immune checkpoint inhibitors regime in patients with unresectable hepatocellular carcinoma (2023 · Journal of Gastrointestinal Oncology · 被引 13)
• Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China (2022 · World Journal of Gastroenterology · 被引 12)